12:00 AM
Sep 27, 2010
 |  BC Week In Review  |  Clinical News  |  Preclinical Results

Excelimmune preclinical data

In mice, Excelimmune's human recombinant polyclonal antibody (HRPA) against MRSA produced 100% survival against doses of S. aureus that...

Read the full 71 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >